Leading the World in Patient-First Genomic Science

The ChristianaCare Gene Editing Institute accelerates breakthroughs in CRISPR gene editing to improve human health.

Accelerating Discovery. Advancing Treatment.

Driven by its urgent mission to develop disease-conquering therapies, the Gene Editing Institute both accelerates the science and hones the precision of gene editing. The scientific discoveries of the Institute have led to the development of a highly innovative lung cancer therapy to test CRISPR gene editing in solid tumors for the first time.

About us
Translational Sciences

Translational Sciences

The Gene Editing Institute’s extraordinary team of gene scientists, with input from ChristianaCare oncologists, is pursuing new, life-extending solutions for patients with solid tumors.

Translational Sciences
Gene Editing 360

Gene Editing 360TM

Gene Editing 360TM has everything you need to introduce your students to the science behind CRISPR gene editing and launch them on a new journey of learning and discovery.

Education
Discovery Research

Discovery Research

The Gene Editing Institute supports researchers with the tools to do their work more quickly and precisely and seeks ways to make these tools safe and effective for knocking out cancer or genetic diseases like sickle cell. The team developed the first CRISPR tool to repair DNA outside the human cell.

Discovery Research
Our Supporters
Our Supporters
Supporters
Join our Team
Join our Team
Careers
Our Diversity Commitment
Our Diversity Commitment
About Us